Abstract
The ubiquitous role of the endocannabinoid system in food intake and energy metabolism is now established. Drugs that manipulate different aspects of this system may benefit subjects with the metabolic and cachectic syndromes.
| Original language | English |
|---|---|
| Pages (from-to) | 344-348 |
| Number of pages | 5 |
| Journal | Current Opinion in Lipidology |
| Volume | 19 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published or Issued - Aug 2008 |
| Externally published | Yes |
Keywords
- 2-arachidonoylglycerol
- Anandamide
- Endocannabinoid
- Rimonabant
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Molecular Biology
- Genetics
- Nutrition and Dietetics
- Cardiology and Cardiovascular Medicine
- Cell Biology